Autochthonous primary and metastatic melanomas in Hgf-Cdk4 R24C mice evade T-cell-mediated immune surveillance

Pigment Cell & Melanoma Research
Jennifer LandsbergThomas Tüting

Abstract

Genetically engineered mouse models offer new opportunities to investigate the role of cell-mediated immunity in the natural progression of melanoma in an immunocompetent host. Here we report that Hgf-Cdk4(R24C) mice spontaneously develop a spectrum of primary melanomas with high penetrance during their first year of life. Malignant transformation proceeds in a stepwise manner from multiple melanocytic nevi to single nodular melanomas and disseminated metastases in most mice. Migrating melanoma cells invade the draining lymph nodes without activating the immune system. Autochthonous primary tumors are destroyed following experimental introduction of immune surveillance using an adoptive lymphocyte transfer approach. However, some tumor cells are able to survive, evade immune cell control, and recur both locally and systemically. Immune tolerance in recurring tumors may be supported by immunosuppressive Gr1(+) myeloid cells. Taken together, our results demonstrate that primary and metastatic melanomas developing spontaneously in Hgf-Cdk4(R24C) mice effectively evade cellular immune surveillance.

References

Feb 3, 1997·The Journal of Experimental Medicine·M B BloomJ C Yang
Nov 14, 1997·Genes & Development·L ChinR A DePinho
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·K Staveley-O'CarrollH Levitsky
Jun 19, 1998·Biochemistry·W ShaoB I Schweitzer
Oct 20, 1998·Oncogene·M KatoI Nakashima
Mar 23, 2000·International Journal of Cancer. Journal International Du Cancer·J SteitzT Tüting
Sep 21, 2001·Nature·F P NoonanG Merlino
Oct 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·R SotilloM Malumbres
Mar 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jennifer H DufourAndrew D Luster
Nov 26, 2002·Immunological Reviews·Licia RivoltiniGiorgio Parmiani
Aug 20, 2003·The Journal of Experimental Medicine·Willem W OverwijkNicholas P Restifo
Feb 20, 2004·Cancer Research·Renée LengagneArmelle Prévost-Blondel
Mar 23, 2004·Annual Review of Immunology·Gavin P DunnRobert D Schreiber
Mar 4, 2005·The American Journal of Pathology·Verena von FelbertJoachim Weis
Aug 5, 2005·Nature·Chrysiis MichaloglouDaniel S Peeper
Sep 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katsuhide OkunishiKazuhiko Yamamoto
Oct 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Maria Grazia BorrelloMarco A Pierotti
Mar 17, 2006·Cancer Research·Ivo J HuijbersBenoît J Van den Eynde
Mar 23, 2006·Annual Review of Immunology·Thierry BoonPierre van der Bruggen
Jul 11, 2006·The New England Journal of Medicine·Arlo J Miller, Martin C Mihm
Jun 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Linan HaGlenn Merlino
Oct 16, 2007·Pigment Cell Research·Lionel Larue, Friedrich Beermann
Dec 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Renée LengagneArmelle Prévost-Blondel
Feb 16, 2008·Lancet·Alberto MantovaniFrancesco M Marincola
Mar 21, 2008·Pigment Cell & Melanoma Research·Dorothy C Bennett
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Feb 19, 2009·Pigment Cell & Melanoma Research·Ann RichmondYingjun Su
Apr 17, 2009·Pigment Cell & Melanoma Research·Vladislava O Melnikova, Menashe Bar-Eli
Sep 9, 2009·Pigment Cell & Melanoma Research·Camilla JandusPedro Romero
Oct 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Silvia KimpflerViktor Umansky
Feb 10, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Srinivas NagarajDmitry I Gabrilovich
Mar 23, 2010·Cell·Sergei I GrivennikovMichael Karin
Mar 25, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mahdia BenkhouchaPatrice H Lalive
Apr 22, 2010·Cancer Research·Saïdi M SoudjaAnne-Marie Schmitt-Verhulst

❮ Previous
Next ❯

Citations

Jun 16, 2012·Clinical & Experimental Metastasis·Stuart G JarrettDavid M Kaetzel
Mar 29, 2013·Nature Reviews. Cancer·Michael HölzelThomas Tüting
Oct 12, 2011·Pigment Cell & Melanoma Research·Graeme J WalkerNeil F Box
Jan 24, 2013·PloS One·Christian BuschUlrich Drews
Feb 7, 2016·Journal of the National Cancer Institute·Diwakar DavarJohn M Kirkwood
Dec 19, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J ChenX D Zhang
Jan 6, 2011·International Journal of Cancer. Journal International Du Cancer·Evelyn GaffalThomas Tüting
Dec 12, 2012·Pigment Cell & Melanoma Research·Nathalie Auphan-AnezinAnne-Marie Schmitt-Verhulst
Jul 31, 2013·Immunity·Jasper G van den Boorn, Gunther Hartmann
Dec 5, 2017·Melanoma Research·Louise van der WeydenDavid J Adams
Nov 30, 2019·BMC Medical Genomics·Eric BlancDieter Beule
Feb 3, 2016·Cold Spring Harbor Protocols·Farhia KabeerKatrina Podsypanina

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.